Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia 30Neoplasms 16Lung Neoplasms 3Breast Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Small Cell Lung Carcinoma 1Pleural Effusion, Malignant 1Pleural Effusion 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Genital Neoplasms, Female 1Fatigue 1Carcinoma 1

Interventions

Modafinil 2reparixin 1clazakizumab 1Walking 1Sodium Chloride 1Saline Solution 1Methylphenidate 1Lenalidomide 1EOM613 1Darbepoetin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Fatigue × Darbepoetin alfa × Clear all
NCT00117039 2008-10-15

A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia

Amgen

Phase 4 Completed
1,500 enrolled
Classical hematology

Anemia, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡